Riskpilot← Back to searchSign inGet full accessOrtoHelSan AB
ABActiveOrg 5569282014Övre Slottsgatan 10Research and experimental development on natural sciences and engineering · NACE 7210Est. 20131 employees
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
53.4%
Financial strength
Net profit 2024
SEK -11K
0% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -11K | +0% |
| Net profit | SEK -11K | +0% |
| Total assets | SEK 58K | +0% |
| Equity | SEK 31K | +0% |
| Employees | 1 | — |
Legal name
OrtoHelSan AB
Org number
5569282014
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9 april 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso- och sjukvård med ortopedisk inriktning.
Address
Övre Slottsgatan 10
Email
bengt.sanden@uu.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −14 | −71 | −10 | −11 | −11 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −14 | −71 | −10 | −11 | −11 |
| Net financials | — | — | — | 1 | 1 |
| Profit before tax | −2 | −37 | −11 | −11 | −11 |
| Tax | −1 | −1 | 1 | −0 | −0 |
| Net profit | −3 | −38 | −10 | −11 | −11 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 150 | 78 | 69 | 58 | 58 |
| Equity | 89 | 51 | 42 | 31 | 31 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 27 | 27 | 27 | 27 | 27 |
| Total debt | 27 | 27 | 27 | 27 | 27 |
EBITDA margin
-1100000.0%
This company
15.8%
Market median
-6962125% vs market
20202024
Equity ratio
53.4%
This company
38.2%
Market median
+40% vs market
20202024
Return on equity
-35.5%
This company
18.4%
Market median
-293% vs market
20202024
Net profit margin
-1100000.0%
This company
8.1%
Market median
-13580347% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PJ Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Deputy Board Member | 2026 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2026 | |
| Chairman | 2021 – 2026 | |
| Board of Directors | 2021 – 2026 | |
| Deputy Board Member | 2021 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OrtoHelSan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Jonas Bergquist | Chief Executive Officer | 0 companies |
| Nanna Linnea Bergquist | Deputy Board Member | 0 companies |
| Ingrid Maria Sandén | Deputy Board Member | 0 companies |
| Bengt Gösta Sandén | Chairman | 0 companies |
| Hans-Olov Hellström | Board of Directors | 0 companies |
| Molly Lovisa Bergquist | Deputy Board Member | 0 companies |
| Maritta Susanne Hellström Pigg | Deputy Board Member | 0 companies |